1960s–1970s

Today’s Opening Luncheon Kicks Off Four Days of Exhibit Hall Happenings

Make your way to Exhibit Hall A & B1 today beginning at 11:30 a.m. for the always popular Opening Luncheon that will kick off four days of happenings you won’t want to miss! Open daily from 11:30 a.m. to 4:00 p.m. through Wednesday (and through 6:00 p.m. on Monday), the Exhibit Hall promises to be jam-packed with countless opportunities to explore, discover, and connect through interactive exhibits, events, and experiences. Learn about the latest advancements in patient care, find products that add efficiencies to your practice, and gather resources that assist patients and caregivers. Building a trip to the Exhibit Hall into your Annual Meeting schedule is the only way to get new information from the diverse, neurologyfocused companies that are here to help you and your patients. Use the AAN Conferences mobile app to find more details and locations about specific exhibitors! Additionally, the Exhibit Hall gives you the opportunity to:

• Have a cup of coffee or specialty hot or iced espresso drink at the Buzz Cafes. Whether you prefer regular or decaf, vegan or half & half, there’s a coffee beverage for you!

• Relax and recharge your devices—and yourself—while connecting to colleagues from the variety of comfortable seating options and locations in the Exhibit Hall Charging Lounges. Even those on the go can charge their devices in the safety of the Charging Lockers.

• Welcome the return of the Innovation Hub with physician talks, paint and wine, and virtual reality experience!

• Discover cutting-edge technologies and therapies in the Emerging Technologies Neighborhood.

• Learn about pipeline products, new notable companies, and more at the Emerging Neurologic Care Presentation Stage.

• Enjoy food and fun at the Monday evening Networking Crawl from 4:00 p.m.–6:00 p.m. Remember to Complete Your ‘Passport’

to Win Prizes!

Remember to complete your Exhibit Hall Passport for a chance to win prizes, including a grand prize drawing of a 2024 Annual Meeting registration and a three-night stay in an AAN block hotel—compliments of the Academy. Passports are available in the Exhibit Hall. Opening Luncheon sponsored by Viatris Inc.

Rare Inspiration. Changing Lives.

Alexion is now investigating 2 new treatments for generalized myasthenia gravis (gMG).

For over 30 years, Alexion’s mission has been to deepen our understanding and transform the lives of people who are affected by rare diseases and living with devastating conditions. We bring this same steadfast commitment to patients with generalized myasthenia gravis (gMG).

ALXN2050. The ExpanD Study is a phase 2 study evaluating the oral investigational medication ALXN2050 for the treatment of gMG.

ALXN2050 is an inhibitor of complement factor D, a component of the alternative pathway, which is being investigated as a novel mechanism of action for the treatment of adults with gMG.

ALXN1720. The Prevail Study is a phase 3 study evaluating Alexion’s new complement component C5 inhibitor, gefurulimab (ALXN1720), for the treatment of adults with gMG.

Gefurulimab is developed for selfadministration through once-weekly subcutaneous injection, which would provide patients with more autonomy and greater flexibility to benefit from a mechanism of action that is well established.

NCT05218096

NCT05556096

Saniya Pervin @PervinSaniya

Kick starting Day 1 at #AANAM with the plenary session “Controversies in #Neurology ” #neurotwitter @AANmember

ThienThanh Nguyen, MD @ThienThanhNgu15

Starting Day 1 with Enhanced resident Leadership program at #AANAM #neurotwitter @AANmember @NeuroUky

Annika Ehrlich, MS, FNP-C, CNRN, AQH @EhrlichNP

Neurologist and Headache specialist @DrHopeMO kicking off @AANmember #AANAMso excited to start the day, my first time attending an in person annual meeting!!!

Bert Vargas @BertVargas

In my room planning the day @ #AANAM while rocking those @AANmember socks!

Shravan Sivakumar @sshravanMD

Starting #AANAM #boston with a golden ticket! #neurotwitter @umassneurology

Anishee Undavia, MD @AnisheeShah

In a new era where instead of stating disclosures the speaker first affirms that they did not use chat gpt #neurotwitter #aanam